August 24, 2018
My colleagues at UCSF have submitted this public comment to FDA regarding RJR's application to sell Camel Snus as a reduced risk product. The tracking number at regulations.gov is 1k2-9510-3zjn. A PDF of the comment is here.
Docket number: FDA-2017-N-4678-0001
Reynolds’ own data do not support their claim that because exclusive users of Camel Snus experience lower levels of exposure to some toxicants, they will reduce their risk of harm from lung cancer, oral cancer, respiratory disease, and heart disease
August 24, 2018
Bonnie Halpern Felsher from Stanford, in collaboration with colleagues at UCSF submitted this comment to FDA on RJR's application to market Camel Snus as a less dangerous product. The tracking number on regulations.gov is 1k2-9510-ujes. A PDF of the comment is available here.
Docket Number: FDA-2017-N-4678-0001
August 24, 2018
August 24, 2018
My colleagues at UCSF and I have submitted this public comment to FDA on the RJ Reynolds application to market Camel Snus as a reduced risk tobacco product. The regulations.gov tracking number is 1k2-9510-wmcl. A PDF of the comment is available here.
Docket Number: FDA-2017-N-4678-0001
The Dynamic Population Modeler (+1) Used to Show Population Health Benefits Does Not Justify Issuing a MRTP Order for Camel SNUS Products
August 22, 2018
Our colleagues at the Public Healh Institute have prepared several public comments on California's cannabis regulations that they have offered as models for others. In addition to the comments themselves, Lynn Silver's transmittal email (below) sums up the current state of play in California pretty well. The point about preempting local laws is particularly troubling as is the fact that BCC plans to run the research program rather than relying on an independent agency like UC.
Comment to California Department of Public Health, Bureau of Cannabis Control, Department of Food and Agriculture.
Dear Colleagues,